Drimva

Ginkgo Bioworks

Senior Director, Multiomics

$183K–$290K

Boston, Massachusetts +1 · Director · Full-time · Posted Aug 7, 2026

Location
Boston, Massachusetts
Boston, Massachusetts, United States
Experience
10+ years in high-growth biotech or large pharma.
Education
PhD (or equivalent experience) in genomics, molecular biology, computational biology, systems biology, or a related field.

About the job

Leads the scientific, operational, and commercial growth of Ginkgo Datapoints’ arrayed multiomics business, including its perturbation profiling platform and full P&L.

What you'll do

  • Set the Multiomics go-to-market strategy, pricing, revenue growth, and operational efficiency.
  • Direct the scientific roadmap and scale automated arrayed perturbation and multiomic readout capabilities, including AI-ready data generation.
  • Lead and mentor a multidisciplinary team, represent the business externally, and partner on government programs and grants.

What they ask for

  • 10+ years in high-growth biotech or large pharma with a proven record in functional genomics and discovery research.
  • Active buyer of discovery, CRO, or data-generation services, or led teams that bought them.
  • PhD or equivalent experience in genomics, molecular biology, computational biology, systems biology, or a related field.
  • Direct experience with arrayed chemical and/or genetic screening (CRISPR KO / CRISPRi), transcriptomic profiling, and high-content imaging; practical understanding of wetlab methods.

Nice to have

  • Experience with translational or clinical biomarkers, proteomics, metabolomics, or additional NGS methods.
  • AI/ML or lab automation expertise; commercial-growth, grant, or multiomics-community experience.

Pay

$183,000–$290,000 USD base salary

Tools

DRUG-seq, Cell Painting, CRISPR KO, CRISPRi, siRNA, ASO, proteomics, metabolomics

AI focus

Shape perturbation data generation for AI/ML model training and lead integrated QC and AI analytics pipelines producing AI-ready datasets.

Model-written summary · the original posting is authoritative

First seen Oct 27, 2026 · Last verified Nov 5, 2026 (UTC)